We also knocked down CCL26 in OXTRHigh CAFs and established an orthotopic model of OSCC, and demonstrated that CCL26 knockdown could impair OXTRHigh CAFs-supported tumor growth and LNM (Supplementary Fig. 6c), which is consistent with the findings in Fig. 7d. Here, CCL26 is linked to neoplasm.